Single Ascending Dose Study of MEDI1341 in Healthy Volunteers

Trial Identifier: D6340C00001
Sponsor: AstraZeneca
Collaborator:
Covance, Inc
MMS Holdings, Inc
Catalent Pharma Solutions
Takeda Pharmaceutical Company Ltd
Start Date: October 2017
Primary Completion Date: March 2021
Study Completion Date: March 2021
Condition: Neurological & Brain - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, TX Dallas, TX, US, 75247
US, WI Madison, WI, US, 53704